Cytotoxic T lymphocytes against HIV
- PMID: 1693514
- DOI: 10.1097/00002030-199003000-00001
Cytotoxic T lymphocytes against HIV
Abstract
HIV-1 infection has clearly been shown to induce a vigorous CTL response in infected people, and this response is present at a time when immune function otherwise is globally impaired. HIV-1-specific CTL are detectable both in peripheral blood and tissues of infected people, and are aimed at multiple viral proteins. The precise epitopes recognized by these CTL are now being defined, and the establishment of CTL clones should facilitate further functional analysis of these cells. However, the central question as to the clinical relevance of HIV-1-specific CTL remains. By analogy with animal model systems of virus infection, it is reasonable to postulate that HIV-1-specific CTL serve a protective role as a host defense. In this regard, in vitro data indicate that HIV-1-specific CTL can suppress viral replication, and longitudinal clinical studies indicate that the vigorous CTL activity seen in the early stages of infection declines with disease progression. Alternatively, the presence of HIV-1-specific CTL in tissues such as the lung and brain have to at least raise the possibility that these cells may be contributing to the pathologic consequences of infection. In addition, the relative protective effects of virus-specific CTL compared to other effector mechanisms such as ADCC and neutralizing antibodies remain to be determined. Nevertheless, recent data in the SIV vaccine model give reason for encouragement that a state of protective immunity can be achieved in AIDS-like illness caused by retroviruses. The search continues presently not only for the parameters which define protective immunity in HIV-1 infection, but also for the ideal HIV-1 immunogens to be used for vaccination of human populations.
Similar articles
-
Cytotoxic T lymphocytes in HIV-induced disease: implications for therapy and vaccination.Immunodefic Rev. 1989;1(3):227-46. Immunodefic Rev. 1989. PMID: 2698642 Review.
-
Comparative clonal analysis of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ and CD8+ cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines.J Exp Med. 1992 Dec 1;176(6):1531-42. doi: 10.1084/jem.176.6.1531. J Exp Med. 1992. PMID: 1460417 Free PMC article. Clinical Trial.
-
HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women.Nat Med. 1995 Jan;1(1):59-64. doi: 10.1038/nm0195-59. Nat Med. 1995. PMID: 7584954
-
Identification of overlapping HLA class I-restricted cytotoxic T cell epitopes in a conserved region of the human immunodeficiency virus type 1 envelope glycoprotein: definition of minimum epitopes and analysis of the effects of sequence variation.J Exp Med. 1992 Apr 1;175(4):961-71. doi: 10.1084/jem.175.4.961. J Exp Med. 1992. PMID: 1372650 Free PMC article.
-
Identification of highly conserved and broadly cross-reactive HIV type 1 cytotoxic T lymphocyte epitopes as candidate immunogens for inclusion in Mycobacterium bovis BCG-vectored HIV vaccines.AIDS Res Hum Retroviruses. 2000 Sep 20;16(14):1433-43. doi: 10.1089/08892220050140982. AIDS Res Hum Retroviruses. 2000. PMID: 11018863 Review.
Cited by
-
Significant enlargement of a specific subset of CD3+CD8+ peripheral blood leukocytes mediating cytotoxic T-lymphocyte activity during human immunodeficiency virus infection.Proc Natl Acad Sci U S A. 1993 Oct 15;90(20):9427-30. doi: 10.1073/pnas.90.20.9427. Proc Natl Acad Sci U S A. 1993. PMID: 8415717 Free PMC article.
-
Autoreactive cytotoxic T lymphocytes in human immunodeficiency virus type 1-infected subjects.J Exp Med. 1996 Jun 1;183(6):2509-16. doi: 10.1084/jem.183.6.2509. J Exp Med. 1996. PMID: 8676071 Free PMC article.
-
Changes in natural immunity during the course of HIV-1 infection.Clin Exp Immunol. 1993 Aug;93(2):142-8. doi: 10.1111/j.1365-2249.1993.tb07956.x. Clin Exp Immunol. 1993. PMID: 7688673 Free PMC article.
-
Suppression of HIV replication in the resting CD4+ T cell reservoir by autologous CD8+ T cells: implications for the development of therapeutic strategies.Proc Natl Acad Sci U S A. 2001 Jan 2;98(1):253-8. doi: 10.1073/pnas.98.1.253. Proc Natl Acad Sci U S A. 2001. PMID: 11136258 Free PMC article.
-
CD8+ T cells suppress human immunodeficiency virus replication by inhibiting viral transcription.Proc Natl Acad Sci U S A. 1995 Mar 14;92(6):2308-12. doi: 10.1073/pnas.92.6.2308. Proc Natl Acad Sci U S A. 1995. PMID: 7534418 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources